Renal 1 Flashcards
Renal tubular defects - types
- Fanconi syndrome
- Bartter syndrome
- Gitelman syndrome
- Liddle syndrome
- Syndrome of apparent minelocorticoid excess
Fanconi syndrome - pathophysiology / results in
Generalized reabsorptive defect in early proximal convoluted tubule –> increased amino acids, glucose, HCO3- and PO4- – Metabolic acidosis (proximal renal tubular acidosis)
causes of Fanconi syndrome
- hereditary defects (Wilson disease, tyrosinemia, glycogen storage disease, cystinosis)
- iscemia
- multiple myeloma
- nephrotoxins/drugs (expired tetracyclines, ifosfamide, cisplatin, tenofovir, lead poisoning)
Bartter syndrome - pathophysiology (and result in)
Reabsorptive defect in thick ascending loop oh Henle
–> affects Na+/K+/2CL- cotransporter –>
1. hypokalemia
2. metabolic alkalosis
3. hypercalciuria
LIKE LOOP DIURETICS
Gitelman syndrome - pathophysiology (results in)
Reabsosptive defect in Distal convoluted tubule LIKE THIAZIDE 1. hypokalemia 2. hypomagnesia 3. metabolic alkalosis 4. hypocalciuria
Gitelman syndrome vs Barrter syndrome according to severity
Barrter is more severe
Liddle syndrome - pathophysiology
Gain of function mutation –> increased Na+ reabsorption in collecting tubules (high activity of epithelial channel)
situation that mimics Liddle syndrome
hyperaldosternism (but aldosterone is nearly undetectable)
Liddle syndrome –> ….. (result in)
- hypertension
- hypokalemia
- metabolic alkalosis
- low aldosterone
Liddle syndrome - mode of inheritance / treatment
AD
amiloride
Syndrome of Apparent Mineralocorticoid excess - pathophysiology
hereditary deficiency of 11β-hydroxysteroid dehydrogenase which normally converts cortisol (can activate mineralocorticoid receptors) to cortizone (inactivate on mineralocorticoid receptors) in cell containing mineralocorticoid receptors –> increased mineralocorticoid activity
Syndrome of Apparent Mineralocorticoid excess - manifestations
- hypertension
- hypokalemia
- metabolic alkalosis
- low serum aldosterone levels
P02, PCO2, HCO3-, ph - normal ranges
PO2: 75-105 mm Hg
PCO2: 33-44 mm Hg
HCO3-: 22-28 mEq/L
pH: 7.35-7.45
Winters formula?? is a formula used to evaluate
respiratory compensation in a metabolic acidosis
PCO2=1.5 (HCO3-) + 8 +/- 2
Winters formula - explanation
If measured PCO2 is bigger than predicted PCO2 –> concominant respiratory acidosis
If measured PCO2 is smaller than predicted –> concomitant respiratory alkalosis
Metabolic alkalosis - DDx
- loop diuretics
- vomiting
- antiacids
- hyperaldosteronism
- thiazide use
- Hypokalemia
- several renal tubular defects
Respiratory alkalosis - DDx
Hyperventilation:
- Hysteria
- Hypoxemia (eg. high altitude)
- Pulmoary embolism
- Tumor
- salicylates (early)
Respiratory acidosis - DDx
Hypoventilation:
- Airway obstruction
- Acute lung disease
- Chronic lung disease
- Opioids/sedatives
- weakening of respiratory muscles
Metabolic acidosis - next step
Check anion gap = Na+ - (CL+HCO3-):
more than 12 –> anion gap metabolic acidosis
8-12 –> normal anion gap metabolic acidosis
anion gap metabolic acidosis - DDx
- Methanol (formic acid)
- Uremia
- Diabetic ketoacidosis
- Propylene glycol
- Iron tablets
- ISONIAZIDE
- Lactic acidosis
- Ethylene glycol (–> oxalic acid)
- Salicilates (late)
normal anion gap metabolic acidosis - DDx
- Hyperalimentation (artificial supply of nutrients, typically intravenously)
- Addison disease
- Renal tubular acidosis
- Diarrhea
- Acetazolamide
- Spironolactone
- saline infusion
Renal tubular acidosis - types
- Distal tubular acidosis (type 1)
- Proximal renal tubular acidosis (type 2)
- Combined proximal and distal renal tubular acidosis (type 3)
- Hyperkalemic renal tubular acidosis (type 4)
Metabolic acidosis - predicted compensatory response
1 meq/L decrease in HCO3- –> 1.3 mmHg decrease in PCO2
Metabolic alkalosis - predicted compensatory response
1 meq/L increase in HCO3- –> 0.7 mmHg increase in PCO2
Respiratory acidosis - predicted compensatory response
acute: 1 mmHg increase in PCO2 –> 0.1 meg/L increase in HCO3-
chronic: 1 mmHg increase in PCO2 –> 0.4 meq/L increase in HCO3-
Respiratory alkalosis - predicted compensatory response
acute: 1 mmHg decrease in PCO2 –> 0.2 meq/L decrease in HCO3-
chronic: 1mmHg decrease in PCO2 –> 0.4 meg/L decrease in HCO3-
Renal cell carcinoma - risk factors
- Smoking
- obesity
- gene deletion of chromosome 3 (sporadic or inheritance as von Hippel-Lindau
Renal cell carcinoma - paraneoplastic syndromes
- EPO
- ACTH
- PTHrP
- RENIN
Renal cell carcinoma - prognosis? (why)
poor:
- Resistant to chemotherapy and radiation therapy
- Silent cancer –> comonly presents as a metastatic neoplasm
Renal oncocytoma - clinical manifestations
- painless hematuria
- flank pain
- abdominal mass
Renal oncocytoma - treatment
often resected to exclude malignancy
Squamous cell carcinoma of the bladder - clinical manifestation
painless hematuria
Squamous cell carcinoma of the bladder - risk factors
- Schistosoma haematobium infection (Middle East)
- Chrinic cystitis
- smoking
- chronic nephrolithiasis
Transition cell carcinoma - manifestations
painless hematuria
Calcium oxalate stones are precipitated by (beside low ph)
- ethylene glycol (antifreeze) ingestion
- vitamin C abuse
- malabsorption (Crohn disease)
- hypocitraturia –> low ph
kidney calcium stone treatment
calcium oxalate –> thiazides, citrate, low-sodium diet
calcium phosphate –> thiazides
Ammonium magnesium phosphate stone (sturvite) are caused by
infection with urease + bugs (eg. Proteus mirabilis, Staphylococcus saprophyticus, Klebsiella) that hydrolize urea to ammonia –> urina alkalization
Ammonium magnesium phosphate stones (sturvite) - treatment
- eradication of underling infection
2. surgical removal of stone
Uric acid stones - risk factors
- low sodium diet
- alkalinization of urine
- chelating agents if refractory
kidney stones - types and urine crystals
- Calcium oxalate –> shaped like envelope or dumbbell
- Caclicum phosphate –> wedge-shaped prism
- Ammonium magnesium phosphate –> coffin lid
- Uric acid –> Rhomboid or rosettes
- Cystine –> hexagonal
Urinary incontinence - types
- Stress incontinence
- Urgency incontinence
- Mixed incontinence
- Overflow incontinence
urinary Stress incontinence - mechanism
Outlet incompetence (urethral hypermodility or intrinsic sphincteric deficiency –> leak with high intra-abdominal pressure (eg. sneezing, lifting)
urinary Stress incontinence - increased risk with
obesity
vaginal delivery
prostate surgery
urinary Stress incontinence - management
kegel exercise, weight loss. pessaries
urinary Urgency incontinence - mechanism
Overactive bladder (detrusor instability) –> leak with urge to void immediately
urinary Urgency incontinence - treatment
- pelvic floor muscle strengthening (Kegel) exercise
- bladder training (timed voiding, distraction and relaxation techniques)
- antimuscarinics (oxybutynin)
Overflow incontinence - mechanism
incomplete emptying (detrusor underactivity - weak to emoty the bladder or outlet obstruction) –> leak with overfilling –> increased postvoid residual (urinary retention) on cathetirization or ultrasound
Overflow incontinence - treatment
catherterization relieve obstruction (α-blockers for BPH)